Outset Medical PE Ratio 2019-2024 | OM

Current and historical p/e ratio for Outset Medical (OM) from 2019 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Outset Medical PE ratio as of May 02, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Outset Medical PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-05-02 12.25 0.00
2024-12-31 16.65 $-37.18 0.00
2024-09-30 10.16 $-41.38 0.00
2024-06-30 57.75 $-47.08 0.00
2024-03-31 33.30 $-50.67 0.00
2023-12-31 81.15 $-52.47 0.00
2023-09-30 163.20 $-53.82 0.00
2023-06-30 328.05 $-52.62 0.00
2023-03-31 276.00 $-52.92 0.00
2022-12-31 387.30 $-51.13 0.00
2022-09-30 238.95 $-51.27 0.00
2022-06-30 222.90 $-48.28 0.00
2022-03-31 681.00 $-44.38 0.00
2021-12-31 691.35 $-43.18 0.00
2021-09-30 741.60 $-41.38 0.00
2021-06-30 749.70 $-83.21 0.00
Sector Industry Market Cap Revenue
Medical MEDICAL INFO SYS $0.044B $0.114B
Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) US $38.476B 53.14
Tempus AI (TEM) US $9.826B 0.00
Hims & Hers Health (HIMS) US $9.069B 145.79
Inspire Medical Systems (INSP) US $4.756B 92.38
IRhythm Technologies (IRTC) US $4.186B 0.00
Privia Health (PRVA) US $2.829B 212.00
Enovis (ENOV) US $2.016B 12.47
Schrodinger (SDGR) US $1.847B 0.00
Clover Health Investments (CLOV) US $1.706B 0.00
Phreesia (PHR) US $1.512B 0.00
Omnicell (OMCL) US $1.460B 31.48
Azenta (AZTA) US $1.232B 57.36
10x Genomics (TXG) US $1.031B 0.00
Fulgent Genetics (FLGT) US $0.634B 0.00
Butterfly Network (BFLY) US $0.566B 0.00
Talkspace (TALK) US $0.537B 319.00
Veradigm (MDRX) US $0.476B 0.00
Standard BioTools (LAB) US $0.456B 0.00
TruBridge (TBRG) US $0.392B 0.00
Claritev (CTEV) US $0.362B 0.00
Health Catalyst (HCAT) US $0.294B 0.00
Nyxoah SA (NYXH) BE $0.208B 0.00
SOPHiA GENETICS SA (SOPH) CH $0.202B 0.00
Pulmonx (LUNG) US $0.152B 0.00
American Well (AMWL) US $0.116B 0.00
EUDA Health Holdings (EUDA) SG $0.097B 0.00
Retrieve Medical Holdings (RMHI) US $0.085B 0.00
MDxHealth SA (MDXH) BE $0.081B 0.00
CareCloud (CCLD) US $0.080B 3.43
111 (YI) CN $0.072B 0.00
P3 Health Partners (PIII) US $0.063B 0.00
HeartBeam (BEAT) US $0.061B 0.00
Zepp Health (ZEPP) CN $0.039B 0.00
Zhongchao (ZCMD) CN $0.029B 0.00
ImmunoPrecise Antibodies (IPA) CA $0.021B 0.00
Bullfrog AI Holdings (BFRG) US $0.017B 0.00
MSP Recovery (MSPR) US $0.016B 0.00
Streamline Health Solutions (STRM) US $0.013B 0.00
Precipio (PRPO) US $0.011B 0.00
Strata Skin Sciences (SSKN) US $0.011B 0.00
Predictive Oncology (POAI) US $0.010B 0.00
Healthcare Triangle (HCTI) US $0.009B 0.00
Movano (MOVE) US $0.006B 0.00
Mobile-health Network Solutions (MNDR) SG $0.005B 0.00
HeartSciences (HSCS) US $0.004B 0.00
Tivic Health Systems (TIVC) US $0.003B 0.00
Future Health ESG (FHLT) US $0.000B 0.00